...
首页> 外文期刊>Frontiers in Neurology >Acoustic CR Neuromodulation Therapy for Subjective Tonal Tinnitus: A Review of Clinical Outcomes in an Independent Audiology Practice Setting
【24h】

Acoustic CR Neuromodulation Therapy for Subjective Tonal Tinnitus: A Review of Clinical Outcomes in an Independent Audiology Practice Setting

机译:主观音调耳鸣的声学CR神经调节疗法:在独立的听力学实践环境中的临床结果的审查。

获取原文

摘要

Objective: To describe the quantitative treatment outcomes of patients undergoing acoustic coordinated reset (CR) neuromodulation at a single independent audiology practice over a 22- to 26-week period as part of an open label, non-randomized, non-controlled observational study. Methods: Sixty-six patients with subjective tonal tinnitus were treated with acoustic CR neuromodulation with a retrospective review of patient records being performed in order to identify changes of visual analog scale (VAS, n ?=?66) and in the score of the tinnitus handicap questionnaire (THQ, n ?=?51). Patients had their tinnitus severity recorded prior to the initiation of therapy using the tinnitus handicap inventory in order to categorize patients into slight up to catastrophic impact categories. THQ and VAS for tinnitus loudness/annoyance were obtained at the patient’s initial visit, at 10–14 and 22–26?weeks. Results: Visual analog scale scores were significantly improved, demonstrating a 25.8% mean reduction in tinnitus loudness and a 32% mean reduction in tinnitus annoyance with a clinically significant reduction in percept loudness and annoyance being recorded in 59.1 and 72.7% of the patient group. THQ scores were significantly improved by 19.4% after 22–26?weeks of therapy compared to baseline. Conclusion: Acoustic CR neuromodulation therapy appears to be a practical and promising treatment for subjective tonal tinnitus. However, due to the lack of a control group it is difficult to reach an absolute conclusion regarding to what extent the observed effects are related directly to the acoustic CR neuromodulation therapy. Also, as the observed patient group was made up of paying clients it is unknown as to whether this could have caused any additional placebo like effects to influence the final results.
机译:目的:描述作为开放标签,非随机,非对照观察性研究的一部分,在22到26周的时间内,在一次独立的听力学实践中,对接受声学协调重置(CR)神经调节的患者的定量治疗结果。方法:对66例主观音调性耳鸣患者进行听觉CR神经调节治疗,并回顾性回顾患者的病历,以发现视觉模拟量表(VAS,n?=?66)和耳鸣评分的变化。障碍问卷(THQ,n?=?51)。在开始治疗之前,使用耳鸣残障清单记录患者的耳鸣严重程度,以便将患者分类为轻度至灾难性影响类别。在患者初次就诊时(第10-14周和第22-26周)获得了THQ和VAS用于耳鸣响度/烦恼。结果:视觉模拟量表评分得到显着改善,表明耳鸣响度平均降低25.8%,耳鸣烦恼平均降低32%,在患者组中分别有59.1%和72.7%的知觉响度和烦恼显着降低。与基线相比,治疗22–26周后,THQ得分显着提高了19.4%。结论:声学CR神经调节治疗似乎是主观色调耳鸣的实用和有希望的治疗。但是,由于缺乏对照组,很难就观察到的效果与声学CR神经调节疗法直接相关的程度得出绝对结论。而且,由于观察的患者组由付费客户组成,因此尚不清楚这是否可能引起任何其他类似安慰剂的效应来影响最终结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号